Latest Covid-19 vaccine offers strong protection against symptomatic infection, including from JN.1, early CDC data shows
Briefly

Everything from this study is reassuring that the vaccines are providing the protection that we expected, said Ruth Link-Gelles, lead author of the new study who heads the CDC's vaccine effectiveness program for Covid and RSV.
While we don't have an estimate of vaccine effectiveness specific to immunocompromised people, the fact that the vaccine is working in the general population provides, I think, reassurance for the whole population.
Read at www.mercurynews.com
[
add
]
[
|
|
]